Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line

FASEB Journal

Volumn 11, Issue 12, 1997, Pages 947-953

  Del Bufalo, Donatella ^a   Biroccio, Annamaria ^a   Leonetti, Carlo ^a   Zupi, Gabriella ^a,b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b Laboratorio Oncogenesi Molecolare   (Italy)

Author keywords

Breast carcinoma; Invasion; Metastasis; Migration

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INVASION; CELL DEATH; CELL IMMORTALIZATION; CELL MIGRATION; GENE EXPRESSION REGULATION; GENE MUTATION; GROWTH REGULATION; HUMAN; HUMAN CELL; ONCOGENE C MYC; ONCOGENE RAS; PRIORITY JOURNAL;

MUS MUSCULUS;

EID: 0030868245     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.11.12.9337147     Document Type: Article

References (44)

1. Fearon, E. R., and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell 61, 759-767
2. Bishop, J. M. (1991) Molecular themes in oncogenesis. Cell 64, 235-248
3. Yang, E., and Korsmeyer, S. J. (1996) Molecular Thanatopsis: a discourse on the bcl-2 family and cell death. Blood 88, 386-401
4. Veis, D. J., Sorenson, C. M., Shutter, J. R., and Korsmeyer, S. J. (1993) Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycistic kidneys, and hypopigmented hair. Cell 70, 229-240
5. Hockenbery, D. M., Nunez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (London) 348, 334-336
6. Sentman, C. L., Shutter, J. R, Hockenbery, D., Kanagawa, O., and Korsmeyer, S. J. (1991) Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67, 879-888
7. Hickman, J. A. (1992) Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11, 121-139
8. Seto, M., Jaeger, U., Hockett, R. D., Graminger, W., Bennett, S., Goldman, P., and Korsmeyer, S. J. (1988) Alternative promoters and exons, somatic mutation and down-regulation of the Bcl-2-1g fusion gene in lymphoma. EMBO J. 7, 123-131
9. Fisher, T. C., Milner, A. E., Gregory, C. D., Jackman, A. L., and Aherne, G. W. (1993) Bcl-2 modulation of apoptosis induced by anticancer drugs: resistance pathways thymidylate stress is independent of classical resistance pathways. Cancer Res. 53, 3321-3326
10. Reed, J. C., Haldar, S., Croce, C. M., and Cuddy, M. P. (1990) Complementation by BCL-2 and C-HA-RAS oncogenes in malignant transformation of rat embryo fibroblast. Mol. Cell. Biol. 10, 4370-4374
11. Strasser, A., Harris, A. W., Bath, M. L., and Cory, S. (1990) Novel primitive lymphoid tumors induced in transgenic mice by cooperation between myc and bcl-2. Nature (London) 348, 331-333
12. Fanidi, A., Harrington, E. A., and Evan, G. I. (1992) Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature (London) 359, 554-556
13. Reed, J. C., Cuddy, M., Slabiaak, T., Croce, C. M., and Nowell, P. (1988) Oncogenic potential of bcl-2 demonstrated by gene transfer. Nature (London) 336, 259-261
14. Vaux, D. L., Cory, S., and Adams, J. M. (1988) Bcl-2 oncogene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (London) 335, 440-442
15. Chaoying, Y., Knudson, C. M., Korsmeyer S.J., Dyle, T. V. (1997) Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature (London) 385, 637-640
16. Lu, Q. L., Elia, E., Lucas, S., and Thomas, J. A. (1993) Bcl-2 protooncogene expression in Epstain-Barr-virus-associated nasopharyngeal carcinoma. Int. J. Cancer 53, 29-35
17. Leek, R. D., Kaklamanis, L., Pezzella, F., Gatter, K. C., and Harris, A. L. (1994) Bcl-2 in normal human breast and carcinoma, association with estrogen receptor-positive, epidermal growth factor receptor-negative tumors and in situ cancer. Br. J. Cancer 69, 1135-1139
18. Chan, W. K., Poulsom, R., Lu, Q. L., Patel, K., Gregory, K., Fisher, C. J., and Hanby, A. M. (1993) Bcl-2 expression in invasive mammary carcinoma: correlation with apoptosis, hormone receptors and p53 expression. J. Pathol. 169 (Suppl.), 138
19. Thompson, C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462
20. McConkey, D. J., Greene, G., and Pettaway C. A. (1996) Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line. Cancer Res. 56, 5594-5599
21. Furuya, Y., Krajewski, S., Epstein, J. I., Reed, J. C., and Isaacs, J. T. (1996) Expression of bcl-2 and the progression of human and rodent prostatic cancers. Clin. Cancer Res. 2, 389-398
22. Del Bufalo, D., Biroccio, A., Soddu, S., Laudonio, N., D'Angelo, C., Sacchi, A., and Zupi, G. (1996) Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene. J. Clin. Invest. 98, 1165-1173
23. Leonetti, C., D'Agnano, I., Lozupone, F., Valentini, A., Geiser, T., Zon, G., Calabretta, B., Citro, G., and Zupi, G. (1996) Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and in mice. J. Natl. Cancer Inst. 88, 419-429
24. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M., and McEwan, R. N. (1987) A radip in vitro assay for quantitating the invasive potential of tumor cells Cancer Res. 47, 3239-3245
25. Albini, A., Allavena, G., Melchiori, A., Giancotti, F., Richter, H., Comoglio, P. M., Parodi, S., Martin, G. R., and Tarone, G. (1987) Chemotaxis of 3T3 and SV3T3 cells to fibronectin is mediated through the cell-attachment site in fibronectin and a fibronectin cell surface receptor. J. Cell Biol. 105, 1867-1872
26. Nakjima, M., Lotan, D., Baig, M. M., Carralero, R. M., Wood, C. W., Hendrics, M. J. C., and Lotan, R. (1989) Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res. 49, 1698-1706
27. Mensing, H., Albini, A., Krieg, T., Pontz, B. F., and Muller, P. K. (1984) Enhanced chemotaxis of tumor-derived and virus-transformed cells to fibronectin and fibroblast-conditioned medium. Int. J. Cancer 33, 43-48
28. Nicolson, G. L. (1989) Metastatic tumor cell interaction with endothelium, basement membrane and tissue. Curr. Opin. Cell Biol. 1, 1009-1019
29. Pignatelli, M., Hanby, A. M., and Stamp, G. W. (1991) Low expression of beta 1, alpha 2 and alpha 3 subunits of VLA integrins in malignant mammary tumors. J. Pathol. 165, 25-32
30. Zutter, M. M., Mazoujian, G., and Santoro, S. A. (1990) Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am. J. Pathol. 137, 863-870
31. Mignatti, P., and Rifkin, D. B. (1993) Biology and biochemestry of proteinases in tumor invasion. Physiol. Rev. 73, 161-195
32. Sato, H., Kida, Y., Mai, M., Endo, Y., Sasaki, T., Tanaka, J., and Seiki, M. (1992) Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 7, 77-83
33. Liotta, L. A. (1986) Tumor invasion and metastasis-role of the extracellular matrix. Cancer Res. 46, 1-7
34. Ponta, H., Sleeman J., and Herrlich, P. (1994) Tumor metastasis formation: cell-surface proteins confer metastasis-promoting or -suppressing properties. Biochem. Biophys. Acta 1198, 1-10
35. Raff, M. C. (1992) Social controls on cell survival and cell death. Nature (London) 356, 397-400
36. Colombel, M., Symmans, F., Gil, S., O'Toole, K. M., Chopin, D., Benson, M., Olsson, C. A., Korsmeyer, S., and Buttyan, R. (1993) Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancer. Am. J. Pathol. 143, 390-400
37. Campos, L., Rouault, J. P., Sabido, O., Oriol, P., Roubi, N., Vasselon, C., Archimbaud, E., Magaud, J. P., and Guyotat, D. (1993) High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 81, 3091-3096
38. McDonnell, T. J., Troncoso, P., Brisbai, S. M., Logothetis, C., Chung, W. K., Hsieh, J., Tu, S., and Campbell, L. M. (1992) Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 52, 6940-6944
39. Sierra, A., Lloveras, B., Castellsagué, X., Moreno, L., Garcia-Ramirez, M., and Fabra, A. (1995). Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma. Int. J. Cancer 60, 54-60
40. Leek, R. D., Kaklamanis, L., Pezzella, F., Gatter, K. C., and Harris, A. L. (1994) Bcl-2 in normal human breast and carcinoma, association with estrogen receptor-positive, epidermal growth factor receptor-negative tumors and in situ cancer. Br. J. Cancer 69, 135-139
41. Silvestrini, R., Veneroni, S., Daidone, M. G., Benini, E., Boracchi, P., Mezzetti, M., Di Fronzo, G., Rilke, F., and Veronesi, U. (1994) The bcl-2 protein: A prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patient. J. Natl. Cancer Inst. 86, 499-504
42. Oltavai, Z. N., Milliman, C. L., and Korsmeyer, S. J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homologue, Bax, that accelerates programmed cell death. Cell 74, 609-619
43. Dawson, C. W., Eliopoulos, A. G., Dawson, J., and Young, L. S. (1995) BHRF1, a viral homologue of the Bcl-2 oncogene, disturbs epithelial cell differentiation. Oncogene 10, 69-77
44. Krajewska, M., Krajewska, S., Epstein, J. I., Shabaik, A., Sauvageot, J., Song, K., Kitada, S., and Reed, J. C. (1996) Immunohistochemical analysis of bcl-2, bax, bcl-x, and mcl-1 expression in prostate cancer. Am. J. Pathol. 148, 1567-1576